Target type: biologicalprocess
The chemical reactions and pathways resulting in the formation of a nucleoside diphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with diphosphate on the sugar. [GOC:go_curators, ISBN:0198506732]
Nucleoside diphosphate biosynthetic process is a fundamental metabolic pathway that generates the essential building blocks for DNA, RNA, and a wide array of other cellular molecules. This process involves the synthesis of nucleoside diphosphates (NDPs), which are the precursors for nucleoside triphosphates (NTPs), the activated forms of nucleotides used in DNA replication, RNA transcription, and numerous other cellular processes. The biosynthesis of NDPs typically involves two main steps:
1. **Phosphorylation of a nucleoside monophosphate (NMP) to a nucleoside diphosphate (NDP).** This reaction is catalyzed by nucleoside monophosphate kinases (NMPKs), which are highly conserved enzymes found in all organisms. NMPKs utilize ATP as a phosphate donor, transferring a phosphate group from ATP to the 5'-hydroxyl group of the NMP, forming the corresponding NDP.
2. **De novo synthesis of NDPs from simpler precursors.** This pathway involves a series of enzymatic reactions that assemble the nucleotide base and the ribose-5-phosphate moiety, followed by the addition of two phosphate groups. The specific enzymes involved vary depending on the particular nucleoside diphosphate being synthesized, but the overall process involves the conversion of amino acids, carbohydrates, and other small molecules into the building blocks of nucleotides.
The biosynthesis of NDPs is tightly regulated to ensure that the appropriate levels of these essential molecules are maintained. This regulation is achieved through a combination of mechanisms, including allosteric control of enzyme activity, feedback inhibition, and changes in gene expression. Defects in nucleoside diphosphate biosynthesis can lead to a variety of genetic disorders, including severe combined immunodeficiency (SCID) and Lesch-Nyhan syndrome. These disorders highlight the critical role of this pathway in human health and development.'
"
Protein | Definition | Taxonomy |
---|---|---|
Ectonucleoside triphosphate diphosphohydrolase 8 | An ectonucleoside triphosphate diphosphohydrolase 8 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q5MY95] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
suramin | suramin : A member of the class of phenylureas that is urea in which each of the amino groups has been substituted by a 3-({2-methyl-5-[(4,6,8-trisulfo-1-naphthyl)carbamoyl]phenyl}carbamoyl)phenyl group. An activator of both the rabbit skeletal muscle RyR1 and sheep cardiac RyR2 isoform ryanodine receptor channels, it has been used for the treatment of human African trypanosomiasis for over 100 years. Suramin: A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties. | naphthalenesulfonic acid; phenylureas; secondary carboxamide | angiogenesis inhibitor; antinematodal drug; antineoplastic agent; apoptosis inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; GABA antagonist; GABA-gated chloride channel antagonist; purinergic receptor P2 antagonist; ryanodine receptor agonist; trypanocidal drug |